Application of CETP detection reagent in preparation of lung cancer screening kit
A kit and reagent technology, applied in the field of in vitro diagnostic reagents, can solve problems such as CETP protein that has not yet been seen, and achieve good application prospects, effective screening, and low patient harm
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0025] The relationship between CETP and lung cancer in embodiment 1 plasma
[0026] 1. Clinical data
[0027] Select 40 cases of lung cancer patients and 40 cases of healthy controls. The basic information is as follows:
[0028] Basic Information lung cancer patients healthy control number of people 40 40 age 58.8±11.5 50.1±14.3 male ratio 33(82.5%) 17(44.7%)
[0029] 2. Detection principle
[0030] Same as the basic enzyme-linked immunosorbent assay (ELISA) detection method.
[0031] CETP protein CETP antibody (specifically recognizes the ASYPDITGEK amino acid sequence of CETP protein (SEQ ID NO.1)) is immobilized on the protein chip. After incubation with plasma exosome protein, if there is CETP protein in the exosome protein, the CETP protein It will bind; wash to remove unbound antibodies and other proteins, then use fluorescently labeled CETP antibody to bind to CETP protein for detection, and read the signal through a fluoresce...
Embodiment 2
[0051] Embodiment 2 The composition of detection kit of the present invention and its application method
[0052] 1. Kit composition
[0053] Detection kit (14 persons):
[0054]
[0055]
[0056] The reagents for preparing plasma exosomal proteins need to be prepared by themselves, which can be commercially available plasma exosomal protein extraction kits.
[0057] 2. How to use the kit
[0058] Same as the third part of Example 1.
[0059]The kit of the present invention can detect the risk of lung cancer in the population to be tested by detecting the level of CETP in plasma exosomes: if the CETP level is high (relative to healthy controls), the risk of lung cancer is high, and if CETP Low levels are associated with a low risk of lung cancer. It can be used for auxiliary diagnosis of clinical lung cancer, and provide effective basis for patients to take relevant treatment measures or decision-making, and has a good clinical application prospect.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com